#Antibodies

ilker oztop

iLKIR

FYI on the #COVID19 #RussianVaccine - tested in an open label, non-randomized phase 1+2 (no placebo) in 38 people combined. Safety monitoring for 2 mo only. cannot even detect common

Jen Heemstra

jenheemstra

Scientific studies have shown that it’s possible to get reinfected with COVID-19, but also that immunity could last for years. How can that be and what does it mean for

jrbundren

jrbundren1

For those who don't know, I own a medical sale company. In an unprecedented time like we're living in now, it's extremely important for me to stay in contact with

Eric Feigl-Ding

DrEricDing

Recent study: Levels of an antibody found in recovered #COVID19 patients fell sharply in 2-3 months after infection for both symptomatic and asymptomatic patients, raising questions about the length of

Chise 🧬🧫🦠💉

sailorrooscout

Let’s talk about B.1.617. It is unlikely it will be able to evade vaccine-induced immunity. Why?•Vaccines are polyclonal (Abs)•Mutations compared to VOCs•CD8+ T-cells covering 52 epitopes across the spike protein•CD4+

Srikanth

copykanth

My understanding of how vaccines work and why you should ABSOLUTELY take them.A thread.PS: I’m not a doctor or scientist. First and foremost, vaccines work.They always have.The chart below illustrates

alice maz

alicemazzy

between the singapore second wave and the confirmation of many if not most cases fully asymptomatic, we really need to start testing random healthy people in hotspots for antibodies because

C. Michael Gibson MD

CMichaelGibson

ThreadAmazing at this point how little we know about #coronavirus:1. We have a range of R0 from 2.0 to 5.7; that is a massive range. 2. Do we know if

#DigitalHealth Futurist 👨‍💻

ManeeshJuneja

Day 41 of lingering #covid19 symptoms – the day is almost at a close, I’ve discussed my negative PCR swab result with my NHS GP today as well as the

Vincent Rajkumar

VincentRK

Astra Zeneca vaccine & blood clots. Summary.Rare form of blood clots plus low platelets. ~60% involve veins of brain. Almost all after 1st dose. Risk (UK MHRA): 1 in 250,000

Peter Kolchinsky

PeterKolchinsky

SARS-2, on the other hand, takes up residence in the throat cells first, which doesn’t cause significant symptoms. The person can remain asymptomatic or might not think they have anything

Rasu Shrestha MD MBA

RasuShrestha

Immune response to #COVID19 peaked about three weeks after the onset and then swiftly declined, finds Dr Katie Doores of @KingsCollegeLon "It puts another nail in the coffin of the

Marisha Ray 🔸

MarishaRayLD

This is the statement on the research to fight #COVID19 taking place in #France at the moment, and below I will place a summary of what is said (Thread).(My own

Zachary Binney

zbinney_NFLinj

The FDA has approved the first antibody test for COVID-19, from Cellex. It theoretically tells you if you've had it & are, as far as we know, immune for some

Eric Topol

EricTopol

Did monoclonal antibodies save the President's life?We'll never know, but it's possible and the implications are profound.Let me explain 1/ Trump's risk profile by demographics was high (age, male, obesity)

Virginia Heffernan

page88

Long walk in a mask. 1. Far from making me reckless; it was inhibiting & never let me forget that even my breath cd be dangerous to the city now.